TLX 0.39% $23.43 telix pharmaceuticals limited

Perfect summary, I concur on all your points. Yes conservatively...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,313 Posts.
    lightbulb Created with Sketch. 574
    Perfect summary, I concur on all your points. Yes conservatively US$30m (q3) + US$30m++ (q4) - $AU35m/q ($US25m) - $AU35m/q ($US25m) = break even in any case. CFO confirmed 45 to 60 days delay in receivables indeed, so Q4 latest shall be the turning point in terms of balance sheet. @Tony barber was right after all:

    https://hotcopper.com.au/threads/2022-chart-thread.6826293/page-129?post_id=62758630

    This will bobble. I still say end of Jan is when this will really move. (Assuming the revenue is on track)
    It's actually probably time to do a PE valuation based on revenue of $22 mil per quarter up to December 31.

    That revenue is a cautious approach but it's where I'd start.


    Meanwhile re Zircon it looks like CB and team all seemed very excited about it so new funds could be flowing in Sept already. DKMA apparently is a formality now so with both these anns + quarterly results on 20 October so SP should hopefully be back in ATH region.

    Thanks for pointing out CB's comments btw concerning "competitive misinformation" lol (I missed that out as I came in 20 min late) so he definitely follows HC drama quite thoroughly and addressed it factually biggrin.png The battle with Lantheus in the US is only starting, quite a good emulation IMO.
    Last edited by spnc: 20/08/22
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.